Martin Morgan S, Smith Alison A, Lobo Monica, Paramesh Anil S
Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA.
Department of Pathology, Tulane University, School of Medicine, New Orleans, LA, USA.
Case Rep Transplant. 2017;2017:1925070. doi: 10.1155/2017/1925070. Epub 2017 Mar 13.
We describe the unusual case of a recently transplanted cadaveric renal transplant recipient who presented with recurrent pulmonary mucormycosis. An 18-year-old man with end stage renal disease secondary to congenital renal agenesis status after cadaveric kidney transplant 4 months before presented with acute onset of fever, hemoptysis, and back pain. The patient underwent an emergent left lower lobectomy due to the critical nature of his illness. He was also treated with amphotericin with resolution of his symptoms. One week later, he had evidence of recurrent disease on imaging with a surgical site infection. He underwent reexploration with evacuation of an empyema and debridement of a surgical site infection. He was continued on IV antifungal therapy with isavuconazonium and amphotericin. Radiographic clearance of disease with three months of treatment was apparent with no evidence of recurrence at seven-month follow-up. Opportunistic infections in solid organ transplant patients represent a significant source of morbidity and mortality. Most patients are treated with prophylactic anti-infective agents. However, rare infections such as pulmonary mucormycosis remain a risk. The transplant physician must be aware of these uncommon infections and their treatment strategies, including the management of uncommon recurrent disease.
我们描述了一例不同寻常的病例,一名近期接受尸体肾移植的受者出现复发性肺毛霉病。一名18岁男性,因先天性肾发育不全导致终末期肾病,在4个月前接受尸体肾移植,现出现发热、咯血和背痛急性发作。由于病情危急,患者接受了急诊左下肺叶切除术。他还接受了两性霉素治疗,症状得到缓解。一周后,影像学检查显示疾病复发,并伴有手术部位感染。他接受了再次探查,排出了脓胸并对手术部位感染进行了清创。他继续接受静脉注射伊曲康唑和两性霉素的抗真菌治疗。经过三个月的治疗,影像学上疾病明显清除,七个月随访时无复发迹象。实体器官移植患者的机会性感染是发病和死亡的重要来源。大多数患者接受预防性抗感染药物治疗。然而,像肺毛霉病这样的罕见感染仍然是一种风险。移植医生必须了解这些不常见的感染及其治疗策略,包括不常见复发性疾病的管理。